Hybridan’s Derren Nathan introduces the hydrogen sector and some of the key players in this expanding sector.
A developer of best-in-class targeted therapeutics has had its near- clinic ready TYK2/JAK 1 inhibitor programme earmarked as a potential therapy for severe Covid-19.
Derren Nathan of Hybridan stockbrokers takes a detailed look at Rural Broadband Solutions, which specialises in providing fibre quality broadband to rural communities.
The tide is beginning to turn for plastic technologies firm Symphony Environmental, writes Derren Nathan of Hybridan.
Derren Nathan of Hybridan explains why Physiomics continues to attract funding to progress its evolving personalised medicine tools.
An accredited NHS software creator is poised to enter a new growth phase with next-generation, digital, clinical-support engines, as healthcare systems worldwide feel the strain.